Carregant...
Novel ABCA1 peptide agonists with antidiabetic action
Previously, apoE-derived ABCA1 agonist peptides have been shown to possess anti-atherosclerotic and possibly antidiabetic properties. Here we assessed the in vitro and in vivo actions of a second generation of ABCA1 peptide agonists, CS6253 and T6991–2, on glucose homeostasis. The results show that...
Guardat en:
| Publicat a: | Mol Cell Endocrinol |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6626528/ https://ncbi.nlm.nih.gov/pubmed/30290217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2018.09.011 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|